Vistin Pharma ASA (VISTN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Vistin Pharma ASA (VISTN)
Company Performance

Current Price

as of Oct 17, 2024

$2.52

P/E Ratio

17.65

Market Cap

$110.08M

Description

Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). It offers Metformin HCI and Metformin DC. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.

Metrics

Overview

  • HQOslo, PS
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerVISTN
  • Price$2.518851+0.39%

Trading Information

  • Market Cap$110.08M
  • Float45.99%
  • Average Daily Volume (1m)23,156
  • Average Daily Volume (3m)35,380
  • EPS$1.54

Company

  • Revenue$440.62M
  • Rev Growth (1yr)-0.61%
  • Net Income$19.16M
  • Gross Margin21.05%
  • EBITDA Margin25.77%
  • EBITDA$27.34M
  • EV$1.03B
  • EV/Revenue2.34
  • P/E17.65
  • P/S2.74
  • P/B4.10
Documents